Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Crispr Therapeutics Ag (NQ: CRSP )

70.66 -0.95 (-1.33%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,861,191
Open 71.17
Bid (Size) 70.38 (1)
Ask (Size) 70.62 (10)
Prev. Close 71.61
Today's Range 69.44 - 71.74
52wk Range 37.55 - 76.19
Shares Outstanding 78,935,098
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Top-Rated Biotech Stocks That Analysts Are Loving Now
Investing in biotech stocks can be tricky, but analysts have bullish outlooks on these three, promising companies. 
Via InvestorPlace
2 Dirt-Cheap Stocks That Could Rocket Higher in a Bull Market
These stocks may take off in a market favoring growth. 
Via The Motley Fool

Performance

YTD
+72.34%
+72.34%
1 Month
+81.51%
+81.51%
3 Month
+39.73%
+39.73%
6 Month
+9.33%
+9.33%
1 Year
+32.47%
+32.47%

More News

Read More
Investing in These 3 Stocks Now Could Make You a Millionaire Retiree
Via The Motley Fool
Is CRISPR Therapeutics the Best Gene-Editing Stock?
Via The Motley Fool
3 Biotech Stocks That Could Be Millionaire Makers
Via The Motley Fool
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
Via Talk Markets
Topics ETFs
What's Going On With Crispr Therapeutics Stock Monday?
Via Benzinga
Google’s Bard AI Says These 3 Stocks Will Rise 1,000%
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall Street
Via The Motley Fool
Could Investing $10,000 In CRISPR Therapeutics Stock Make You a Millionaire?
Via The Motley Fool
3 Monster Stocks in the Making
Via The Motley Fool
Why CRISPR Therapeutics Stock Is Jumping Again Today
Via The Motley Fool
Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
CRISPR Therapeutics Stock Earns 88 RS Rating On U.K. Regulator News
Via Investor's Business Daily
3 Long-Term Growth Stocks Analysts Are Bullish On
Via InvestorPlace
3 Cathie Wood You’ll Regret Not Buying Soon: November 2023
Via InvestorPlace
Why Is NIO Stock Down 5% Today?
Via InvestorPlace
Crispr Surges After Winning The First-Ever Approval For A CRISPR-Based Gene-Editing Drug
Via Investor's Business Daily
What's Going On With Crispr Therapeutics Stock Thursday?
Via Benzinga
Citi Is Souring on Plug Power (PLUG) Stock
Via InvestorPlace
CRISPR Therapeutics (CRSP) Stock Jumps as U.K. Authorizes Gene Therapy
Via InvestorPlace
Exposures Product Safety
UK Approves First Crispr Gene Edited Therapy For Sickle Cell Disease, Beta Thalassemia
Via Benzinga
Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Can CRISPR Therapeutics Stock Double in 5 Years? Here's What It Would Take.
Via The Motley Fool
Vertex and CRISPR Therapeutics Announce Authorization of the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), by the United Kingdom MHRA for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.